These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 9798075)

  • 61. Disruption of prepulse inhibition of startle reflex in a neurodevelopmental model of schizophrenia: reversal by clozapine, olanzapine and risperidone but not by haloperidol.
    Le Pen G; Moreau JL
    Neuropsychopharmacology; 2002 Jul; 27(1):1-11. PubMed ID: 12062902
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficacy of clozapine, olanzapine, risperidone, and haloperidol in schizophrenia and schizoaffective disorder assessed with nurses observation scale for inpatient evaluation.
    Volavka J; Nolan KA; Kline L; Czobor P; Citrome L; Sheitman B; Lindenmayer JP; McEvoy J; Lieberman JA
    Schizophr Res; 2005 Jul; 76(1):127-9. PubMed ID: 15927808
    [No Abstract]   [Full Text] [Related]  

  • 63. Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2.
    Light GA; Swerdlow NR; Thomas ML; Calkins ME; Green MF; Greenwood TA; Gur RE; Gur RC; Lazzeroni LC; Nuechterlein KH; Pela M; Radant AD; Seidman LJ; Sharp RF; Siever LJ; Silverman JM; Sprock J; Stone WS; Sugar CA; Tsuang DW; Tsuang MT; Braff DL; Turetsky BI
    Schizophr Res; 2015 Apr; 163(1-3):63-72. PubMed ID: 25449710
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A machine learning approach using auditory odd-ball responses to investigate the effect of Clozapine therapy.
    Ravan M; Hasey G; Reilly JP; MacCrimmon D; Khodayari-Rostamabad A
    Clin Neurophysiol; 2015 Apr; 126(4):721-30. PubMed ID: 25213349
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clozapine enhances neurocognition and clinical symptomatology more than standard neuroleptics.
    Potkin SG; Fleming K; Jin Y; Gulasekaram B
    J Clin Psychopharmacol; 2001 Oct; 21(5):479-83. PubMed ID: 11593072
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Deficit Effect Sizes and Correlations of Auditory Event-Related Potentials at First Hospitalization in the Schizophrenia Spectrum.
    Salisbury DF; Kohler J; Shenton ME; McCarley RW
    Clin EEG Neurosci; 2020 Jul; 51(4):198-206. PubMed ID: 31390901
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The effects of clozapine on cognitive functioning in schizophrenia.
    McGurk SR
    J Clin Psychiatry; 1999; 60 Suppl 12():24-9. PubMed ID: 10372607
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of perospirone on P300 electrophysiological activity and social cognition in schizophrenia: a three-dimensional analysis with sloreta.
    Sumiyoshi T; Higuchi Y; Itoh T; Matsui M; Arai H; Suzuki M; Kurachi M; Sumiyoshi C; Kawasaki Y
    Psychiatry Res; 2009 Jun; 172(3):180-3. PubMed ID: 19386475
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Auditory evoked potentials as possible predictors of outcome in schizophrenic outpatients.
    Hegerl U; Gaebel W; Gutzman H; Ulrich G
    Int J Psychophysiol; 1988 Aug; 6(3):207-14. PubMed ID: 2900230
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Childhood-onset schizophrenia: A double-blind, randomized clozapine-olanzapine comparison.
    Shaw P; Sporn A; Gogtay N; Overman GP; Greenstein D; Gochman P; Tossell JW; Lenane M; Rapoport JL
    Arch Gen Psychiatry; 2006 Jul; 63(7):721-30. PubMed ID: 16818861
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Nicotine-antipsychotic drug interactions and attentional performance in female rats.
    Rezvani AH; Levin ED
    Eur J Pharmacol; 2004 Feb; 486(2):175-82. PubMed ID: 14975706
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia.
    Breier A; Buchanan RW; Kirkpatrick B; Davis OR; Irish D; Summerfelt A; Carpenter WT
    Am J Psychiatry; 1994 Jan; 151(1):20-6. PubMed ID: 8267129
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia.
    Goff DC; Lamberti JS; Leon AC; Green MF; Miller AL; Patel J; Manschreck T; Freudenreich O; Johnson SA
    Neuropsychopharmacology; 2008 Feb; 33(3):465-72. PubMed ID: 17487227
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Influence of duration of untreated psychosis on auditory P300 in drug-naive and first-episode schizophrenia.
    Wang J; Hirayasu Y; Hokama H; Tanaka S; Kondo T; Zhang M; Xiao Z
    Psychiatry Clin Neurosci; 2005 Apr; 59(2):209-14. PubMed ID: 15823170
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of clozapine on caudate nucleus volume in relation to symptoms of schizophrenia.
    Scheepers FE; Gispen de Wied CC; Hulshoff Pol HE; Kahn RS
    Am J Psychiatry; 2001 Apr; 158(4):644-6. PubMed ID: 11282704
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Haloperidol counteracts the ketamine-induced disruption of processing negativity, but not that of the P300 amplitude.
    Oranje B; Gispen-de Wied CC; Westenberg HG; Kemner C; Verbaten MN; Kahn RS
    Int J Neuropsychopharmacol; 2009 Jul; 12(6):823-32. PubMed ID: 19154656
    [TBL] [Abstract][Full Text] [Related]  

  • 77. MMN/P3a deficits in first episode psychosis: comparing schizophrenia-spectrum and affective-spectrum subgroups.
    Kaur M; Battisti RA; Ward PB; Ahmed A; Hickie IB; Hermens DF
    Schizophr Res; 2011 Aug; 130(1-3):203-9. PubMed ID: 21550211
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Placebo-controlled trial of glycine added to clozapine in schizophrenia.
    Evins AE; Fitzgerald SM; Wine L; Rosselli R; Goff DC
    Am J Psychiatry; 2000 May; 157(5):826-8. PubMed ID: 10784481
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Auditory event-related potential abnormalities in bipolar disorder and schizophrenia.
    O'Donnell BF; Vohs JL; Hetrick WP; Carroll CA; Shekhar A
    Int J Psychophysiol; 2004 Jun; 53(1):45-55. PubMed ID: 15172135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.